Search Results - "RYU, Janice"
-
1
Pelvic Normal Tissue Contouring Guidelines for Radiation Therapy: A Radiation Therapy Oncology Group Consensus Panel Atlas
Published in International journal of radiation oncology, biology, physics (01-07-2012)“…Purpose To define a male and female pelvic normal tissue contouring atlas for Radiation Therapy Oncology Group (RTOG) trials. Methods and Materials One male…”
Get full text
Journal Article Conference Proceeding -
2
The Role of Adjuvant Radiation in Uterine Sarcomas
Published in International journal of radiation oncology, biology, physics (01-03-2010)“…Purpose To determine clinical and pathological factors significant for overall survival (OS) and local-regional failure-free survival (LRFFS) in uterine…”
Get full text
Journal Article -
3
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma
Published in International journal of radiation oncology, biology, physics (01-02-2005)“…To evaluate prospectively the acute and late morbidities from a multiinstitutional three-dimensional radiotherapy dose-escalation study for inoperable…”
Get more information
Journal Article -
4
Long-Term Toxicity Following 3D Conformal Radiation Therapy for Prostate Cancer From the RTOG 9406 Phase I/II Dose Escalation Study
Published in International journal of radiation oncology, biology, physics (01-01-2010)“…Purpose To update the incidence of late toxicity of RTOG 9406, a three-dimensional conformal radiation therapy (3DCRT) dose escalation trial for prostate…”
Get full text
Journal Article -
5
Clinical Outcome of Patients Treated With 3D Conformal Radiation Therapy (3D-CRT) for Prostate Cancer on RTOG 9406
Published in International journal of radiation oncology, biology, physics (01-07-2012)“…Purpose Report of clinical cancer control outcomes on Radiation Therapy Oncology Group (RTOG) 9406, a three-dimensional conformal radiation therapy (3D-CRT)…”
Get full text
Journal Article -
6
The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: A double-blind placebo-controlled prospective Phase III study by Radiation Therapy Oncology Group 9901
Published in International journal of radiation oncology, biology, physics (01-03-2007)“…Purpose: Based on early clinical evidence of potential mucosal protection by granulocyte-macrophage colony stimulating factor (GM-CSF), the Radiation Therapy…”
Get full text
Journal Article -
7
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin
Published in Cancer (01-10-2003)“…BACKGROUND Because studies have suggested that anemia has an adverse effect on outcome for patients with cervical carcinoma who are treated with radiation,…”
Get full text
Journal Article -
8
Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy)
Published in International journal of radiation oncology, biology, physics (15-11-2002)“…A prospective Phase I dose escalation study was conducted to determine the maximally tolerated radiation dose in men treated with three-dimensional conformal…”
Get more information
Journal Article -
9
Phase III Trial of an Emulsion Containing Trolamine for the Prevention of Radiation Dermatitis in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Trial 99-13
Published in Journal of clinical oncology (01-05-2006)“…This multicentered phase III trial was designed to compare an emulsion containing trolamine against the usual supportive care within each participating…”
Get full text
Journal Article -
10
COX-2 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy and celecoxib: a quantitative immunohistochemical analysis of RTOG C0128
Published in International journal of gynecological cancer (01-01-2013)“…This study aimed to measure expression of cyclooxygenase-2 (COX-2) and CD34 in pretreatment tumor biopsies from patients on the RTOG C0128 phase II study, and…”
Get more information
Journal Article -
11
A Phase II study of acute toxicity for Celebrex™ (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: Primary endpoint analysis of RTOG 0128
Published in International journal of radiation oncology, biology, physics (2007)“…Purpose: To determine treatment-related acute toxicity rates in patients with locally advanced cervical cancer treated by oral celecoxib, i.v. cisplatin and…”
Get full text
Journal Article -
12
Changes in Gene Expression Predicting Local Control in Cervical Cancer: Results from Radiation Therapy Oncology Group 0128
Published in Clinical cancer research (15-06-2009)“…Purpose: To evaluate the potential of gene expression signatures to predict response to treatment in locally advanced cervical cancer treated with definitive…”
Get full text
Journal Article -
13
Efficacy and Patterns of Failure for Locally Advanced Cancer of the Cervix Treated With Celebrex (Celecoxib) and Chemoradiotherapy in RTOG 0128
Published in International journal of radiation oncology, biology, physics (01-09-2007)“…Purpose To determine the efficacy and patterns of initial failure for oral celecoxib, intravenous cisplatin, and 5-fluorouracil and concurrent pelvic…”
Get full text
Journal Article -
14
Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer
Published in International journal of radiation oncology, biology, physics (15-11-2006)“…The aim of this study was to develop and validate our own benchmark dose-volume histograms (DVHs) of bladder and rectum for both conventional three-dimensional…”
Get more information
Journal Article -
15
Twice-Weekly Paclitaxel and Weekly Carboplatin With Concurrent Thoracic Radiation Followed by Carboplatin/Paclitaxel Consolidation for Stage III Non–Small-Cell Lung Cancer: A California Cancer Consortium Phase II Trial
Published in Journal of clinical oncology (15-01-2001)“…Recent studies have suggested the superiority of concurrent chemoradiotherapy and the efficacy of paclitaxel/carboplatin in advanced non-small-cell lung cancer…”
Get full text
Journal Article -
16
Utility of Megavoltage Fan-Beam CT for Treatment Planning in a Head-And-Neck Cancer Patient with Extensive Dental Fillings Undergoing Helical Tomotherapy
Published in Medical dosimetry : official journal of the American Association of Medical Dosimetrists (2010)“…Abstract The purpose of this study was to demonstrate the potential utility of megavoltage fan-beam computed tomography (MV-FBCT) for treatment planning in a…”
Get full text
Journal Article -
17
Secondary Supratentorial Primitive Neuroectodermal Tumor following Irradiation in a Patient with Low-Grade Astrocytoma
Published in American journal of neuroradiology : AJNR (01-01-2005)“…We report a case of a supratentorial primitive neuroectodermal tumor (PNET) that occurred 12 years after cranial irradiation for a grade II astrocytoma…”
Get full text
Journal Article -
18
Radiotherapy for breast cancer: today and tomorrow
Published in Cancer biotherapy & radiopharmaceuticals (01-06-2002)“…Breast conservation therapy (BCT) with lumpectomy and radiation has allowed many women to preserve their breasts and avoid disfiguring surgery. Lumpectomy and…”
Get more information
Journal Article -
19
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma
Published in International journal of radiation oncology, biology, physics (01-08-1997)“…To evaluate the influence of fraction size, overall time, total dose, and other prognostic factors on local control of T1 and T2 glottic carcinomas. Between…”
Get more information
Journal Article -
20
Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004)
Published in Clinical cancer research (15-08-2004)“…Purpose: To determine the feasibility and a recommended phase II dose of tirapazamine when combined with chemoradiotherapy in limited-stage small cell lung…”
Get full text
Journal Article